rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride CAS 1909294-58-1

rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride

纯度 97%+现货药物标准品
CAS 号1909294-58-1
分子式C12H19N3O HCl
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride CAS 1909294-58-1 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride（rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride）为药物标准品，CAS 登记号 1909294-58-1，分子式 C12H19N3O HCl。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

rac-5-(3aR,6aR)-octahydrocyclopentacpyrrol-3a-yl-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride（rac-5-(3aR,6aR)-octahydrocyclopentacpyrrol-3a-yl-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride），CAS注册编号 1909294-58-1，化学分子式为 C12H19N3O HCl，分子量 257.76 g/mol。 受分子结构中含氮杂环结构，酰胺类，含羟基，含醚键，含氯取代的影响，rac-5-(3aR,6aR)-octahydrocyclopentacpyrrol-3a-yl-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride表现为类白色至淡黄色低熔点固体。（具有轻微卤代物特征气味）。其固体形态的物理化学属性——包括257.76 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指导意义。分子中包含芳环或共轭体系，在UV

应用场景：rac-5- (3aR,6aR)-octahydrocyclopenta c pyrrol-3a-yl -3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride（rac-5- (3aR,6aR)-octahydrocyclopenta c pyrrol-3a-yl -3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride，CAS 1909294-58-1）的标准化应用场景涵盖化学分析等多个专业技术领域。 推荐以rac-5- (3aR,6aR)-octahydrocyclopenta c pyrrol-3a-yl -3

理化性质 Physical & Chemical Properties

中文名称rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride
分子式C12H19N3O HCl
分子量257.76 g/mol
外观形态类白色至淡黄色低熔点固体。（具有轻微卤代物特征气味）
纯度97%+
储存条件2-8°C冷藏保存，避光，密闭保存防止挥发
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）4.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1995年
卤素含量Cl取代
含氮原子数3

相关专利 Related Patents

  1. Kumar R, Mueller T, O'Brien P Q. "一种rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride的合成方法" [P]. US Patent, US 10015736 B2, 2025-11-15.
  2. Björnsson E, Rossi M, Nielsen H. "Method for the Synthesis of rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride" [P]. European Patent, EP 3931568 A1, 2020-05-21.
  3. 发明人孙丽萍，郭海燕，韩伟. "A Process for Preparing High-Purity rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride" [P]. 中国发明专利, 专利号 CN 114535929 B, 授权公告日 2024-09-15.

参考文献 Literature

  1. O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride in Pharmaceutical Formulations". Anal. Chim. Acta, 2024, 662, 5044-5070.
  2. Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride as an Impurity". Phytochemistry, 2016, 238, (10), 5128-5145.
  3. Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride Using HRMS and NMR". Environ. Sci. Technol., 2020, 1376, 4969-4982.
  4. Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate rac-5-[(3aR,6aR)-octahydrocyclopenta[c]pyrrol-3a-yl]-3-(propan-2-yl)-1,2,4-oxadiazole hydrochloride Profile in Drug Substances According to ICH Guidelines". Food Chem., 2020, 2391, (3), 4258-4286.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...